查詢結果分析
來源資料
頁籤選單縮合
題 名 | 不容忽視的飲食障礙--暴食症=Borderline Eating Disorder: Bulimia Nervosa |
---|---|
作 者 | 林佩姿; 王芙蓉; 李炳鈺; | 書刊名 | 藥學雜誌 |
卷 期 | 26:4=105 2010.12[民99.12] |
頁 次 | 頁47-51 |
分類號 | 415.9982 |
關鍵詞 | 飲食障礙; 暴食症; 認知行為治療; Eating disorder; Bulimia nervosa; Cognitive behavior therapy; |
語 文 | 中文(Chinese) |
中文摘要 | 暴食症是好發於青少年的飲食障礙疾病之一,患者在暴食後常採用激烈的手段來防止體重的增加。近年因受到社會風氣及媒體的影響及對身體形象的誤解和缺乏自信心,暴食症患者有增加的趨勢。暴食症患者經過適當的治療,病情可以獲得改善,認知行為療法及藥物治療對於暴食症皆可以發揮治療效果。認知行為主要是藉由思想影響行為,而達到行為改善效果;藥物治療主要以抗憂鬱藥物為主,其中因 fluoxetine在治療成果及耐受度方面都有良好的成效而為優先選擇,但若以藥物合併認知行為治療將可以獲得最佳療效。 |
英文摘要 | Bulimia nervosa is high prevalence in adolescent, characterized by recurrent episodes of bingeing eating followed by inappropriate compensatory purging behavior to prevent weight gain. In recent year, prevalence rate of bulimia nervosa increase because of less confidence in oneself, disordered of body shape and the social convention and media. Bulimia nervosa can be well controlled by appropriate treatment, such as cognitive behavior therapy and pharmacotherapy. Cognitive behavior therapy is one of psychotherapies that emphasizes the important role of thinking and influence behaviors by thinking to achieve an objective of changing inappropriate behavior. Antidepressants have been demonstrated to be effective in reducing the bulimia symptoms, and fluoxetine is the drug of choice between antidepressant medications because it shows good therapeutic efficacy and tolerance. Studies have been demonstrated that pharmacotherapy combine with cognitive behavior therapy would obtain the best treatment effect. |
本系統中英文摘要資訊取自各篇刊載內容。